ID: h-var-002f522b52
Hypothesis

Activity-Dependent CD55/CD46 Trafficking and Synaptic Surface Localization

The activity-dependent trafficking of complement regulators CD55 and CD46 to synaptic surfaces represents a dynamic regulatory mechanism controlling complement-mediated synaptic pruning through vesicular transport and membrane insertion.
🧬 CD55 (DAF), CD46 (MCP)🩺 synaptic-biology🎯 Composite 83%validated
synaptic biology
EvidencePending (0%)📖 18 cit🗣 1 debates 9 support 2 oppose
⚠ Low Validation Senate Quality Gates →
Mechanistic 0.75 (15%) Evidence 0.72 (15%) Novelty 0.75 (12%) Feasibility 0.70 (12%) Impact 0.80 (12%) Druggability 0.70 (10%) Safety 0.50 (8%) Competition 0.80 (6%) Data Avail. 0.55 (5%) Reproducible 0.72 (5%) KG Connect 0.50 (8%) 0.833 composite

🧪 Overview

The activity-dependent trafficking of complement regulators CD55 and CD46 to synaptic surfaces represents a dynamic regulatory mechanism controlling complement-mediated synaptic pruning through vesicular transport and membrane insertion. Rather than static differential expression, CD55 and CD46 undergo rapid, activity-dependent translocation from intracellular vesicular pools to synaptic membranes via SNARE-mediated exocytosis. High-frequency synaptic activity triggers calcium influx through NMDA receptors and voltage-gated calcium channels, activating CaMKII-dependent phosphorylation of synaptotagmin-1 and synaptotagmin-7, which serve as calcium sensors for CD55/CD46-containing vesicles. These specialized complement regulator vesicles, distinct from classical synaptic vesicles, are stored in perisynaptic endosomal compartments and contain both CD55 and CD46 pre-clustered with adaptor proteins including AP-2 and clathrin. Upon calcium-triggered fusion, these vesicles rapidly insert complement regulators into the postsynaptic membrane through interaction with SNARE proteins VAMP2/3 on vesicles and syntaxin-1/SNAP-25 complexes at target membranes.

...

🧬 Mechanism

🧬 Curated Mechanism Pathway

Curated pathway from expert analysis

flowchart TD
    A["CD55 DAF, CD46 MCP<br/>Hypothesis Target"]
    B["Complement<br/>Cited Mechanism"]
    C["Cellular Response<br/>Stress or Clearance Change"]
    D["Neural Circuit Effect<br/>Synapse/Glia Vulnerability"]
    E["Neurodegeneration<br/>Disease-Relevant Outcome"]
    A --> B
    B --> C
    C --> D
    D --> E
    style A fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
    style B fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
    style E fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a

⚖️ Evidence

⚖️ Evidence Matrix9 supports2 contradicts
Supports
CD55 protects synapses from complement-mediated damage
Supports
C3aR1 mediates microglial recruitment to injured neurons
Supports
Dendritic spine CD46 expression is activity-dependent
Supports
Beyond the Role of CD55 as a Complement Component.
Immune Netw2018PMID:29503741medium
Supports
Silencing EGFR-upregulated expression of CD55 and CD59 activates the complement system and sensitizes lung cancer to checkpoint blockade.
Nat Cancer2022PMID:36271172medium
Supports
Nitric oxide induces segregation of decay accelerating factor (DAF or CD55) from the membrane lipid-rafts and its internalization in human endometrial cells.
Cell Biol Int2012PMID:22574734medium
Supports
Role of transcription factor Sp1 and RNA binding protein HuR in the downregulation of Dr+ Escherichia coli receptor protein decay accelerating factor (DAF or CD55) by nitric oxide.
FEBS J2013PMID:23176121medium
Supports
Cell surface CD55 traffics to the nucleus leading to cisplatin resistance and stemness by inducing PRC2 and H3K27 trimethylation on chromatin in ovarian cancer.
Mol Cancer2024PMID:38853277medium
Supports
Calcium influx through NMDA receptors and voltage-gated calcium channels activates CaMKII-dependent phosphorylation of synaptotagmin-1 and synaptotagmin-7 on CD55/CD46-containing vesicles
Contradicts
C1q binding can occur independent of complement cascade initiation through pattern recognition
Contradicts
Global complement enhancement could impair necessary synaptic remodeling
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — CD55

No curated PDB or AlphaFold mapping for CD55 yet. Search RCSB →

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for CD55 (DAF), CD46 (MCP) →

No DepMap CRISPR Chronos data found for CD55 (DAF), CD46 (MCP).

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

💰 Estimated Development
Cost
$0
Timeline

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▲ 0.0%
Volatility
Low
0.0000
Events (7d)
0

💾 Resource Usage

LLM Tokens
27,622
$0.0829
Total Cost
$0.0829
Metadatasource: v1_phase_c_backfill · origin_type: debate_synthesizer
sourcev1_phase_c_backfill
origin_typedebate_synthesizer
_schema_version1
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.